CUAMC
PHAT icon

China Universal Asset Management Company’s Phathom Pharmaceuticals PHAT Stock Holding History

China Universal Asset Management Company’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Sell
12,693
-1,290
-9% -$14.7K 0.01% 388
2026
Q1 		$155K Buy
13,983
+2,391
+21% +$30.2K 0.01% 372
2025
Q4 		$192K Sell
11,592
-843
-7% -$12K 0.01% 347
2025
Q3 		$146K Sell
12,435
-1,587
-11% -$16.4K 0.01% 356
2025
Q2 		$134K Buy
14,022
+307
+2% +$1.7K 0.01% 340
2025
Q1 		$86K Sell
13,715
-784
-5% -$4.76K 0.01% 370
2024
Q4 		$118K Buy
14,499
+1,365
+10% +$16.9K 0.01% 375
2024
Q3 		$237K Buy
13,134
+6,257
+91% +$87.5K 0.03% 286
2024
Q2 		$70.8K Sell
6,877
-4,112
-37% -$42.4K 0.01% 328
2024
Q1 		$117K Buy
10,989
+4,363
+66% +$37.1K 0.01% 356
2023
Q4 		$60.5K Buy
6,626
+5,171
+355% +$44.6K 0.01% 349
2023
Q3 		$15.1K Buy
1,455
+738
+103% +$10.1K ﹤0.01% 315
2023
Q2 		$10.3K Buy
717
+153
+27% +$1.76K ﹤0.01% 316
2023
Q1 		$4.03K Buy
564
+141
+33% +$1.24K ﹤0.01% 389
2022
Q4 		$4.75K Buy
423
+56
+15% +$577 ﹤0.01% 304
2022
Q3 		$4K Buy
+367
New +$3.5K ﹤0.01% 307

Other funds holding PHAT

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

China Universal Asset Management Company's PHAT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Phathom Pharmaceuticals (PHAT) stake by 9.2% in Q2 2026, selling an estimated $14.7K and leaving 12,693 shares worth $138K. The position accounts for 0.01% of the portfolio, ranked #388.

China Universal Asset Management Company first reported a position in PHAT in Q3 2022 and has held it in 16 quarters since. The position peaked at $237K in Q3 2024. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • China Universal Asset Management Company held 12,693 shares of Phathom Pharmaceuticals worth $138K as of Q2 2026.
  • China Universal Asset Management Company sold 1,290 Phathom Pharmaceuticals shares in Q2 2026, an estimated $14.7K.
  • Phathom Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #388 holding.
  • China Universal Asset Management Company first reported a position in Phathom Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Phathom Pharmaceuticals position peaked at $237K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.